AMICUS THERAPEUTICS, INC. Business Combination, Contingent Consideration, Liability
AMICUS THERAPEUTICS, INC. had Business Combination, Contingent Consideration, Liability of $13.01 million as of 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2024-02-28
- 2023-06-30: Business Combination, Contingent Consideration, Liability $13.01M.
- 2023-03-31: Business Combination, Contingent Consideration, Liability $12.67M.
- 2022-12-31: Business Combination, Contingent Consideration, Liability $21.42M.
- 2022-09-30: Business Combination, Contingent Consideration, Liability $19.83M.
| Period end | Business Combination, Contingent Consideration, Liability |
|---|---|
| 2023-06-30 | $13.01M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $12.67M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $21.42M 10-K · filed 2024-02-28 |
| 2022-09-30 | $19.83M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $19.27M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $19.15M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $20.34M 10-K · filed 2023-03-01 |
| 2021-09-30 | $24.61M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $27.32M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $26.30M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $25.82M 10-K · filed 2022-02-24 |
| 2020-09-30 | $25.36M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $24.33M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $23.61M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $22.68M 10-K · filed 2021-03-01 |
| 2019-09-30 | $22.04M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $21.25M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $20.77M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $19.70M 10-K · filed 2020-03-02 |
| 2018-09-30 | $28.10M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $26.80M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $26.50M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $25.40M 10-K · filed 2019-02-28 |
| 2017-09-30 | $21.10M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $265.35M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $274.30M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $269.72M 10-K · filed 2018-03-01 |
| 2016-09-30 | $272.19M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $276.30M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $277.23M 10-Q · filed 2016-08-09 |
| 2015-12-31 | $274.08M 10-K/A · filed 2017-03-03 |
| 2015-09-30 | $282.98M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $11.80M 10-Q · filed 2016-08-09 |
| 2015-03-31 | $11.70M 10-Q · filed 2016-08-09 |
| 2014-12-31 | $10.70M 10-Q · filed 2016-08-09 |
| 2014-09-30 | $10.20M 10-Q · filed 2015-11-04 |
| 2014-06-30 | $10.80M 10-Q · filed 2015-11-04 |
| 2014-03-31 | $11.11M 10-Q · filed 2014-05-05 |
| 2013-12-31 | $10.60M 10-K · filed 2016-02-29 |
| 2013-11-30 | $10.60M 10-K · filed 2016-02-29 |